CATALYST PHARMACEUTICALS INC (CPRX) — insider trading
Health Care · NASDAQ
CATALYST PHARMACEUTICALS INC (CPRX) has 159 reported SEC Form 4 insider transactions in our data (latest 2026-07-15).
Recent Form 4 transactions
Showing the 100 most recent of 159 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | Kalb Michael Wayne | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 39,701 | — | $0 | Form 4 |
| 2026-07-15 | Kalb Michael Wayne | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 13,788 | — | $0 | Form 4 |
| 2026-07-15 | Kalb Michael Wayne | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 21,416 | — | $0 | Form 4 |
| 2026-07-15 | Kalb Michael Wayne | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 131,536 | — | $0 | Form 4 |
| 2026-07-15 | Kalb Michael Wayne | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 169,248 | — | $0 | Form 4 |
| 2026-07-15 | Kalb Michael Wayne | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 257,214 | — | $0 | Form 4 |
| 2026-07-15 | Kalb Michael Wayne | Officer (Chief Financial Officer) | Disposition to the issuer | 13,665 | $31.50 | $430.4K | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer (derivative) | 5,468 | — | $0 | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer (derivative) | 1,894 | — | $0 | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer (derivative) | 1,414 | — | $0 | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer (derivative) | 18,115 | — | $0 | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer (derivative) | 23,248 | — | $0 | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer (derivative) | 29,524 | — | $0 | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer (derivative) | 12,500 | — | $0 | Form 4 |
| 2026-07-15 | Harper Molly | Director | Disposition to the issuer | 3,694 | $31.50 | $116.4K | Form 4 |
| 2026-07-15 | Andrews William T. | Officer (Chief Medical Officer) | Disposition to the issuer (derivative) | 29,776 | — | $0 | Form 4 |
| 2026-07-15 | Andrews William T. | Officer (Chief Medical Officer) | Disposition to the issuer (derivative) | 12,209 | — | $0 | Form 4 |
| 2026-07-15 | Andrews William T. | Officer (Chief Medical Officer) | Disposition to the issuer (derivative) | 98,652 | — | $0 | Form 4 |
| 2026-07-15 | Andrews William T. | Officer (Chief Medical Officer) | Disposition to the issuer (derivative) | 124,447 | — | $0 | Form 4 |
| 2026-07-15 | Andrews William T. | Officer (Chief Medical Officer) | Disposition to the issuer | 2,309 | $31.50 | $72.7K | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 115,283 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 40,013 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 126,316 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 381,948 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 491,160 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 1,365,319 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer (derivative) | 33,500 | — | $0 | Form 4 |
| 2026-07-15 | Daly Richard J | Director, Officer (President and CEO) | Disposition to the issuer | 271,266 | $31.50 | $8.54M | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer (derivative) | 32,257 | — | $0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer (derivative) | 11,206 | — | $0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer (derivative) | 6,855 | — | $0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer (derivative) | 106,873 | — | $0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer (derivative) | 137,553 | — | $0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer (derivative) | 143,193 | — | $0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer (derivative) | 68,000 | — | $0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer (derivative) | 67,500 | — | $0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer (derivative) | 225,000 | — | $0 | Form 4 |
| 2026-07-15 | Sundaram Preethi | Officer (Chief Strategy Officer) | Disposition to the issuer | 54,804 | $31.50 | $1.73M | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 32,257 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 11,206 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 8,039 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 106,873 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 137,553 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 167,918 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 88,000 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 135,000 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 200,000 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer (derivative) | 150,000 | — | $0 | Form 4 |
| 2026-07-15 | Del Carmen Jeffrey | Officer (Chief Commercial Officer) | Disposition to the issuer | 14,337 | $31.50 | $451.6K | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 5,468 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 1,894 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 1,414 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 18,115 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 23,248 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 29,524 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer (derivative) | 33,500 | — | $0 | Form 4 |
| 2026-07-15 | DENKHAUS DONALD A | Director | Disposition to the issuer | 498,773 | $31.50 | $15.71M | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 10,540 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 3,552 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 3,534 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 34,921 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 43,591 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 73,810 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 272,000 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 270,000 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 400,000 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer (derivative) | 740,000 | — | $0 | Form 4 |
| 2026-07-15 | MCENANY PATRICK J | Director, Other | Disposition to the issuer | 4,171,559 | $31.50 | $131.40M | Form 4 |
| 2026-07-15 | Russo Gregg | Officer (Chief HR Officer) | Disposition to the issuer (derivative) | 6,197 | — | $0 | Form 4 |
| 2026-07-15 | Russo Gregg | Officer (Chief HR Officer) | Disposition to the issuer (derivative) | 2,752 | — | $0 | Form 4 |
| 2026-07-15 | Russo Gregg | Officer (Chief HR Officer) | Disposition to the issuer (derivative) | 20,531 | — | $0 | Form 4 |
| 2026-07-15 | Russo Gregg | Officer (Chief HR Officer) | Disposition to the issuer (derivative) | 20,349 | — | $0 | Form 4 |
| 2026-07-15 | Russo Gregg | Officer (Chief HR Officer) | Disposition to the issuer (derivative) | 6,957 | — | $0 | Form 4 |
| 2026-07-15 | Russo Gregg | Officer (Chief HR Officer) | Disposition to the issuer (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-07-15 | Russo Gregg | Officer (Chief HR Officer) | Disposition to the issuer | 476 | $31.50 | $15.0K | Form 4 |
| 2026-07-15 | Thompson Tamar | Director | Disposition to the issuer (derivative) | 5,468 | — | $0 | Form 4 |
| 2026-07-15 | Thompson Tamar | Director | Disposition to the issuer (derivative) | 1,894 | — | $0 | Form 4 |
| 2026-07-15 | Thompson Tamar | Director | Disposition to the issuer (derivative) | 1,414 | — | $0 | Form 4 |
| 2026-07-15 | Thompson Tamar | Director | Disposition to the issuer (derivative) | 18,115 | — | $0 | Form 4 |
| 2026-07-15 | Thompson Tamar | Director | Disposition to the issuer (derivative) | 23,248 | — | $0 | Form 4 |
| 2026-07-15 | Thompson Tamar | Director | Disposition to the issuer (derivative) | 29,524 | — | $0 | Form 4 |
| 2026-07-15 | Thompson Tamar | Director | Disposition to the issuer (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-07-15 | Thompson Tamar | Director | Disposition to the issuer | 3,773 | $31.50 | $118.8K | Form 4 |
| 2026-07-15 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Disposition to the issuer (derivative) | 47,826 | — | $0 | Form 4 |
| 2026-07-15 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Disposition to the issuer (derivative) | 16,534 | — | $0 | Form 4 |
| 2026-07-15 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Disposition to the issuer (derivative) | 11,873 | — | $0 | Form 4 |
| 2026-07-15 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Disposition to the issuer (derivative) | 158,454 | — | $0 | Form 4 |
| 2026-07-15 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Disposition to the issuer (derivative) | 202,958 | — | $0 | Form 4 |
| 2026-07-15 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Disposition to the issuer (derivative) | 248,004 | — | $0 | Form 4 |
| 2026-07-15 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Disposition to the issuer (derivative) | 146,000 | — | $0 | Form 4 |
| 2026-07-15 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Disposition to the issuer (derivative) | 185,000 | — | $0 | Form 4 |
| 2026-07-15 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Disposition to the issuer (derivative) | 275,000 | — | $0 | Form 4 |
Ask the chat about CPRX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CATALYST PHARMACEUTICALS INC (CPRX).
Last updated 2026-07-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.